Toxoplasma oculopathy, unspecified
ICD-10 B58.00 is a billable code used to indicate a diagnosis of toxoplasma oculopathy, unspecified.
Toxoplasma oculopathy is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals. The condition is characterized by inflammation of the retina and choroid, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. The infection is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with infected cat feces. In immunocompetent individuals, Toxoplasma oculopathy may be asymptomatic or present with mild symptoms, while in immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy, the disease can progress rapidly and lead to severe complications. Diagnosis is typically made through clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography or optical coherence tomography. Treatment usually involves the use of antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, including visual acuity and fundoscopic findings.
Patients presenting with blurred vision, floaters, or acute vision loss.
Documentation must clearly indicate the presence of Toxoplasma oculopathy and any associated systemic symptoms.
Comprehensive patient history, including immunocompromised status and serological test results.
Patients with HIV/AIDS presenting with ocular symptoms.
Consideration of co-infections and the need for multidisciplinary management.
Used for follow-up visits in patients diagnosed with Toxoplasma oculopathy.
Complete ocular examination findings and any changes in visual acuity.
Ophthalmologists should document the rationale for the examination and any treatment adjustments.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain or redness.
Diagnosis is made through clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography.
Treatment typically involves antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation.
